Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Federal Interagency Working Group for Diabetes Committee, Work group, Advisory group, or Task Force FDA NIA One of three Federal Interagency Working Groups formed as part of the National Action Plan to Prevent Adverse Drug Events.
Federal Interagency Working Group for Infants and Children Affected by Zika Virus Committee, Work group, Advisory group, or Task Force ACF, ACL, CDC, CMS, HRSA, OS, SAMHSA NICHD This working group brings scientists from multiple Federal agencies together to coordinate research and consider cross-cutting initiatives for children affected by Zika.
Federal Interagency Working Group for Research on Race and Ethnicity Committee, Work group, Advisory group, or Task Force CDC, CMS, OS NICHD The Working Group explores measurement of race and ethnicity. It prepares recommendations to OMB and other Federal agencies for the development, testing, and usage of race and ethnicity designations to more accurately describe minority populations.
Federal Interagency Working Group on Improving Measurement of Sexual Orientation and Gender Identity in Federal Surveys Committee, Work group, Advisory group, or Task Force ACF, CDC, CMS, HRSA, IHS, OS, SAMHSA OD/DPSCSI/SGMRO, NICHD The Working Group explores measurement of sexual orientation and gender identity (SOGI), considering multiple different dimensions of sex, gender, and sexuality. The Working Group examines variability in measurement by age, race, ethnicity, and cultural group. It prepares recommendations to OMB and other Federal agencies for the development, testing, and usage of SOGI measures to more accurately describe LGBT populations.
Federal Partners Committee on Women and Trauma Committee, Work group, Advisory group, or Task Force ACF, AHRQ, CDC, HRSA, SAMHSA NIDA, NIAID, NIMH, OD/DPCPSI/ORWH Led by the Department of Labor (DOL) and Substance Abuse and Mental Health Services Administration (SAMHSA), the Women and Trauma workgroup includes more than three dozen federal agencies, departments, and offices one of the largest interagency collaborations in federal government history.
Federal Partners in Bullying Prevention, Intervention, and Recovery Committee, Work group, Advisory group, or Task Force ACF, CDC, HRSA, IHS, SAMHSA NIMH, NIAAA, NICHD, NIDA This workgroup meets to provide a forum through which staff from relevant federal agencies can communicate and exchange ideas concerning how to prevent or stop bullying in schools and communities.
Federal RePORTER Resource Development ACF, ACL, AHRQ, CDC, FDA OD/OER Federal RePORTER is a searchable public database of scientific awards from federal agencies, which allows for portfolio analysis and metrics development across scientific domains. The trans-federal agency consortium called STAR METRICS (Science and Technology for America’s Reinvestment Measuring the Effects of Research on Innovation, Competitiveness, and Science) designed, created, and maintains Federal RePORTER.
Federal Sudden Unexpected Infant Death/Sudden Infant Death Syndrome (SUID/SIDS) Workgroup Committee, Work group, Advisory group, or Task Force ACF, CDC, FDA, HRSA, IHS, OS NICHD The Federal SUID/SIDS Workgroup represents multiple federal agencies that have established a partnership to coordinate activities, research, and outreach related to reducing infant mortality caused by SUID and SIDS.
Federal Supply and Demand of Isotopes Committee, Work group, Advisory group, or Task Force FDA NIBIB, NCI This workgroup was formed as a follow-up to the Inaugural Workshop on Isotope Federal Supply and Demand, a workshop now held annually. The workgroup consists of representatives of Federal agencies with the aim of providing a forum for interaction between agencies and departments to communicate about potential shortages of isotopes that are of strategic importance to the nation including the availability of medical isotopes. DOE is charged with the production of isotopes that are not commercially available, and coordinates the informational and production efforts. Dr. Roderic Pettigrew, Director of NIBIB is the NIH point of contact on this topic. The workgroup holds an annual workshop that includes all Federal agencies that use isotopes; the workshop promotes discussion on the use, supply and demand of isotopes in various areas including homeland defense, medicine, agriculture, and basic and applied research. The fifth workshop was held in November 2016. An NIH representative participated as a panel member at a congressional briefing on this topic in December 2014. The event was co-sponsored by the American Chemical Society and Research America!
Federal Working Group on Bone Diseases Committee, Work group, Advisory group, or Task Force AHRQ, CDC, CMS, FDA NIAMS, CSR, NCCIH, NCI, NEI, NIA, NIAAA, NICHD, NIDCR, NIDDK, OD/DPCPSI/ODS, OD/DPCPSI/ORWH An interagency committee focusing on osteoporosis and other bone disorders. It offers a forum for sharing information, learning from each other and invited speakers, and facilitating the development, early in the planning stages, of collaborative research activities based on each agency''s mission.